Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment
Clinical trial NCT01320111 · COMPLETED
Trial details
- NCT number
- NCT01320111
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2014-08-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.